This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1997:17:80-113.

DNA topoisomerase I inhibitors

C H Takimoto¹, L V Kieffer, S G Arbuck

Affiliations

PMID: 9551210

Review

DNA topoisomerase I inhibitors

C H Takimoto et al. Cancer Chemother Biol Response Modif. 1997.

. 1997:17:80-113.

Authors

C H Takimoto¹, L V Kieffer, S G Arbuck

Affiliation

¹ Navy Medical Oncology Branch, National Cancer Institute, Naval Hospital Bethesda, MD 20889-5105, USA.

PMID: 9551210

No abstract available

PubMed Disclaimer

Similar articles

DNA topoisomerase I poisons.
Takimoto CH, Kieffer LV, Kieffer ME, Arbuck SG, Wright J. Takimoto CH, et al. Cancer Chemother Biol Response Modif. 1999;18:81-124. Cancer Chemother Biol Response Modif. 1999. PMID: 10800479 Review. No abstract available.
An overview of topoisomerase I-targeting agents.
Arbuck SG, Takimoto CH. Arbuck SG, et al. Semin Hematol. 1998 Jul;35(3 Suppl 4):3-12. Semin Hematol. 1998. PMID: 9779876 Review.
The development of camptothecin analogs in childhood cancers.
Bomgaars L, Berg SL, Blaney SM. Bomgaars L, et al. Oncologist. 2001;6(6):506-16. doi: 10.1634/theoncologist.6-6-506. Oncologist. 2001. PMID: 11743213 Review.
Clinical trials using irinotecan.
Houghton PJ, Santana VM. Houghton PJ, et al. J Pediatr Hematol Oncol. 2002 Feb;24(2):84-5. doi: 10.1097/00043426-200202000-00002. J Pediatr Hematol Oncol. 2002. PMID: 11990709 No abstract available.
DNA topoisomerase I-targeting drugs as radiation sensitizers.
Chen AY, Choy H, Rothenberg ML. Chen AY, et al. Oncology (Williston Park). 1999 Oct;13(10 Suppl 5):39-46. Oncology (Williston Park). 1999. PMID: 10550825 Review.

See all similar articles

Cited by

Non-invasive fluorescence imaging of cell death in fresh human colon epithelia treated with 5-Fluorouracil, CPT-11 and/or TRAIL.
Finnberg N, Kim SH, Furth EE, Liu JJ, Russo P, Piccoli DA, Grimberg A, El-Deiry WS. Finnberg N, et al. Cancer Biol Ther. 2005 Sep;4(9):937-42. doi: 10.4161/cbt.4.9.2182. Epub 2005 Sep 18. Cancer Biol Ther. 2005. PMID: 16251801 Free PMC article.
Testing of the topoisomerase 1 inhibitor Genz-644282 by the pediatric preclinical testing program.
Houghton PJ, Lock R, Carol H, Morton CL, Gorlick R, Anders Kolb E, Keir ST, Reynolds CP, Kang MH, Maris JM, Billups CA, Zhang MX, Madden SL, Teicher BA, Smith MA. Houghton PJ, et al. Pediatr Blood Cancer. 2012 Feb;58(2):200-9. doi: 10.1002/pbc.23016. Epub 2011 May 5. Pediatr Blood Cancer. 2012. PMID: 21548007 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Research Materials
- NCI CPTC Antibody Characterization Program